Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare Biotechnology

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc

Bullboard Posts

Comment by Stylesson Oct 30, 2013 12:17pm

73 Views

Post# 21862058

RE:Styless is about to come out and brag about his prediction

keep blaminng people who have nothing to do iwth it. Those are real sell orders. Guys are getting out and profiting from smart trades made in the 6s just a month ago. I applaud them all. If you believe it's just manipulation, then over time, it will get to your target price as broksters only have so many shares to manipulate (which isn't going on today btw). Anyways, good luck.

Bullboard Posts

Covalon Technologies posts third profitable quarter in a row